Related Experiment Videos
Cost-benefit analysis of pediatric cochlear implantation: German experience
Heide Schulze-Gattermann1, A Illg, M Schoenermark
1The Boston Consulting Group, Hamburg, Germany. schulze-gattermann.heide@bcg.com
Insights
Pediatric cochlear implantation offers a favorable cost-benefit ratio compared to hearing aids for children with hearing loss. Early implantation, before age two, is particularly recommended for optimal outcomes.
Area of Science:
- Audiology
- Health Economics
- Pediatric Medicine
Background:
- Congenital and prelingual deafness significantly impact child development and incur long-term costs.
- Hearing aids are a common intervention, but their long-term cost-benefit is debated compared to newer technologies.
- Understanding the economic implications for payers is crucial for healthcare policy decisions.
Purpose of the Study:
- To evaluate the cost-benefit ratio of pediatric cochlear implantation versus hearing aids from a payer's perspective.
- To test the hypothesis that earlier implantation age correlates with lower overall costs.
- To compare total costs, including educational and associated expenses, for different intervention groups.
Main Methods:
- A comparative study involving children with cochlear implants (implanted at ages 0-1.9, 2-3.9, and 4-6.9 years) and children using hearing aids.
- Cost analysis included direct, indirect, and educational costs, with sick funds and public authorities as payers.
- Data were collected using 1999 currency values, with scenario analysis for cost and discount rate variations.
Main Results:
- Total costs for cochlear implantation ranged from €138,000 to €177,000.
- Costs for hearing aid users were approximately €160,000.
- These findings suggest comparable or potentially lower overall costs for cochlear implant recipients.
Conclusions:
- Pediatric cochlear implantation demonstrates a positive cost-benefit ratio compared to hearing aids, particularly when performed before age two.
- Early implantation is economically advantageous for payers.
- The study supports recommending cochlear implantation for deaf children at younger ages.
Hypothesis:
To explore, from the payers' perspective, the cost-benefit ratio of pediatric cochlear implantation for congenitally deaf and prelingually deafened children compared with children with hearing aids. The study should verify the hypothesis that educational and associated costs increase with age at implantation and that these can be below costs for children with hearing aids.
Methods:
Children who received implants at the Medical University of Hanover at different ages (Group 1, 0-1.9 yr; Group 2, 2-3.9 yr; Group 3, 4-6.9 yr) were compared with deaf children using hearing aids (Group 4). Sick funds were the payers for direct and indirect costs, and public authorities were the payers for educational costs. Educational settings were used to measure for benefits. All costs related to the hearing deficiency were included up to the age of 16 years on the basis of 1999 currency values. A scenario analysis was used to explore the impact of variation of costs and discount rates.
Results:
Total costs for the three age groups of children with implants were from euro 138,000 (approximately US$113,100) to euro 177,000 (approximately US$152,700), compared with euro 160,000 (approximately US$138,000) for hearing aid users.
Conclusion:
This study supports the view that pediatric cochlear implantation provides positive cost-benefit ratios compared with hearing aid users, depending on the age at implantation. Implantation is strongly recommended from the payers' perspective for children implanted before the age of 2 years.